DE2329168A1 - Pharmazeutisches praeparat aus mit 99m-technetium markiertem makroaggregiertem menschlichem serumalbumin - Google Patents
Pharmazeutisches praeparat aus mit 99m-technetium markiertem makroaggregiertem menschlichem serumalbuminInfo
- Publication number
- DE2329168A1 DE2329168A1 DE19732329168 DE2329168A DE2329168A1 DE 2329168 A1 DE2329168 A1 DE 2329168A1 DE 19732329168 DE19732329168 DE 19732329168 DE 2329168 A DE2329168 A DE 2329168A DE 2329168 A1 DE2329168 A1 DE 2329168A1
- Authority
- DE
- Germany
- Prior art keywords
- technetium
- tin
- reagent
- complex
- human serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229910052713 technetium Inorganic materials 0.000 title claims description 17
- GKLVYJBZJHMRIY-UHFFFAOYSA-N technetium atom Chemical compound [Tc] GKLVYJBZJHMRIY-UHFFFAOYSA-N 0.000 title claims description 9
- 102000008100 Human Serum Albumin Human genes 0.000 title claims description 6
- 108091006905 Human Serum Albumin Proteins 0.000 title claims description 6
- 239000000825 pharmaceutical preparation Substances 0.000 title description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 19
- 239000002245 particle Substances 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 11
- 239000002504 physiological saline solution Substances 0.000 claims description 6
- 102000009027 Albumins Human genes 0.000 claims description 4
- 108010088751 Albumins Proteins 0.000 claims description 4
- IUTCEZPPWBHGIX-UHFFFAOYSA-N tin(2+) Chemical compound [Sn+2] IUTCEZPPWBHGIX-UHFFFAOYSA-N 0.000 claims description 4
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 3
- 239000006185 dispersion Substances 0.000 claims description 3
- 210000000056 organ Anatomy 0.000 claims description 3
- 229910021626 Tin(II) chloride Inorganic materials 0.000 claims description 2
- 235000011150 stannous chloride Nutrition 0.000 claims description 2
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 238000013507 mapping Methods 0.000 claims 1
- -1 tin (II) ions Chemical class 0.000 claims 1
- 210000004072 lung Anatomy 0.000 description 7
- 238000003384 imaging method Methods 0.000 description 6
- 238000004220 aggregation Methods 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/081—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the protein being an albumin, e.g. human serum albumin [HSA], bovine serum albumin [BSA], ovalbumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1255—Granulates, agglomerates, microspheres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25967972A | 1972-06-05 | 1972-06-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE2329168A1 true DE2329168A1 (de) | 1974-01-03 |
Family
ID=22985926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19732329168 Withdrawn DE2329168A1 (de) | 1972-06-05 | 1973-06-05 | Pharmazeutisches praeparat aus mit 99m-technetium markiertem makroaggregiertem menschlichem serumalbumin |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPS5761725B2 (enrdf_load_stackoverflow) |
CH (1) | CH574739A5 (enrdf_load_stackoverflow) |
DE (1) | DE2329168A1 (enrdf_load_stackoverflow) |
FR (1) | FR2187307B1 (enrdf_load_stackoverflow) |
GB (1) | GB1389809A (enrdf_load_stackoverflow) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4094965A (en) * | 1977-04-01 | 1978-06-13 | New England Nuclear Corporation | Diagnostic agents containing albumin and method for making same |
CH652599A5 (de) | 1981-08-28 | 1985-11-29 | Solco Basel Ag | Verfahren zur herstellung physiologisch abbaubarer kolloidaler, human-serumalbumin enthaltender produkte und ihre verwendung. |
EP1831373A2 (en) * | 2004-12-22 | 2007-09-12 | Novozymes A/S | Recombinant production of serum albumin |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CS208162B2 (en) * | 1971-07-20 | 1981-08-31 | Thomas A Haney | Method of making the macroagregates of the technicium-99m,albumine and tin ion |
BE786566A (fr) * | 1971-07-20 | 1973-01-22 | Squibb & Sons Inc | Agregats a base de tc-99m et d'albumine |
-
1973
- 1973-05-31 GB GB2597473A patent/GB1389809A/en not_active Expired
- 1973-06-05 JP JP48062605A patent/JPS5761725B2/ja not_active Expired
- 1973-06-05 FR FR7320387A patent/FR2187307B1/fr not_active Expired
- 1973-06-05 CH CH813073A patent/CH574739A5/xx not_active IP Right Cessation
- 1973-06-05 DE DE19732329168 patent/DE2329168A1/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB1389809A (en) | 1975-04-09 |
CH574739A5 (enrdf_load_stackoverflow) | 1976-04-30 |
FR2187307B1 (enrdf_load_stackoverflow) | 1976-10-22 |
JPS4961273A (enrdf_load_stackoverflow) | 1974-06-13 |
FR2187307A1 (enrdf_load_stackoverflow) | 1974-01-18 |
JPS5761725B2 (enrdf_load_stackoverflow) | 1982-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3129906C2 (enrdf_load_stackoverflow) | ||
DE2814038C3 (de) | Mit einem Radionuklid für radioaktive Tests markierbares Material | |
DE2314059A1 (de) | Verbesserte substanz fuer das markieren mit technetium-99m sowie verfahren zu deren herstellung | |
DE2322758A1 (de) | Verfahren zur herstellung von injizierbaren praeparaten des tc99m und/oder in113m und vorrichtung zur durchfuehrung des verfahrens | |
DE2235681A1 (de) | Macroaggregate aus albumin, technetium99m und zinn(ii)-ionen, verfahren zu ihrer herstellung und ihre verwendung als radioindikatoren bei der untersuchung von organen | |
DE2538388A1 (de) | Verfahren zur herstellung eines stabilen, nicht-radioaktiven traegermaterials und seine verwendung zur herstellung von tc-99m-markierten diagnosemitteln | |
DE3237573A1 (de) | Technetium-99m-tri- und tetraphosphonate zur szintigraphischen dastellung res-haltiger organe und der lymphgefaesse und verfahren zu deren herstellung | |
DE2920770A1 (de) | Reduktionsmittel fuer technetium-99m und reduktionsverfahren unter bildung von mit technetium markierten stoffen | |
DE2124752A1 (de) | Verfahren zur Herstellung eines diagnostischen Präparats auf Basis von Makroaggregaten von mit 99mTc markiertem Serumeiweiß | |
DE69914748T2 (de) | Radiojodierte phenole für brachytherapie | |
DE2423167C2 (de) | Radiodiagnostikum, Verfahren zu dessen Herstellung und dessen Verwendung als intravenöse Injektionslösung | |
DE2329168A1 (de) | Pharmazeutisches praeparat aus mit 99m-technetium markiertem makroaggregiertem menschlichem serumalbumin | |
DE2447556A1 (de) | Radiopharmazeutikum | |
Gómez Zapata et al. | Study of postmortem blood circulation | |
US4024233A (en) | 99M-technetium labeled macroaggregated human serum albumin pharmaceutical | |
DE68922858T2 (de) | Bildformungsmittel auf basis von technetium. | |
DE2323097A1 (de) | Mit 99m-technetium markierte zinnkolloide enthaltende radiopharmazeutika | |
DE2125012A1 (de) | Lungenabtastmittel und -verfahren | |
DE3048029A1 (de) | Radioassay-methode fuer warmbluetler zur lokalisierung einer entzuendungsreaktion | |
Sligar et al. | Efferent projections of the septum in the tegu lizard, Tupinambis nigropunctatus | |
Söremark et al. | Autoradiographic studies of the distribution of polonium-210 in mice after a single intravenous injection | |
DE3049533A1 (de) | Radioassaymethode fuer warmbluetler | |
DE2536008C3 (de) | Verfahren zur Herstellung von zur Bindung von Technetium geeigneten zinnhaltigen Humanserumalbumin-Partikeln | |
DE112021007259B4 (de) | Vorrichtung zur Erkennung biologischer Informationen und Verfahren zur Erkennung biologischer Informationen | |
DE1234931B (de) | Roentgenkontrastmittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8139 | Disposal/non-payment of the annual fee |